BEUDAMED
    FDA PMA FDA Class 3 30-Day Notice Accepted 🇺🇸 United States

    Device, Thermal Ablation, Endometrial

    PMA: P970021 · Supplement: S042 · Decision Dec 4, 2014
    View on FDA
    Classifications
    1
    FEI Numbers
    19
    Registration Numbers
    19

    Basic Information

    Device Name
    Device, Thermal Ablation, Endometrial
    Trade Name
    GYNECARE THERMACHOICE III UTERINE BALLOON THERAPY SYSTEM
    PMA Number
    P970021
    Supplement Number
    S042
    Device Class
    FDA Class 3
    Product Code
    MNB
    Generic Name
    Device, thermal ablation, endometrial
    Medical Specialty
    Unknown
    Advisory Committee
    Obstetrics/Gynecology
    Decision
    30-Day Notice Accepted
    Decision Code
    OK30
    Decision Date
    December 4, 2014
    Date Received
    November 5, 2014
    Supplement Type
    30-Day Notice
    Supplement Reason
    Process Change - Manufacturer/Sterilizer/Packager/Supplier
    Expedited Review
    N

    Advisory Committee Statement

    MANUFACTURING CHANGES TO THE GYNECARE THERMACHOICE II CONTROLLER TO MEET AND COMPLY WITH THE EUROPEAN RESTRICTION OF HAZARDOUS SUBSTANCES (ROHS) DIRECTIVE2011/65/EU BY REPLACING NON-ROHS COMPLIANT COMPONENTS WITH FUNCTIONALLY EQUIVALENT ROHS COMPLIANT COMPONENTS.

    Classifications

    This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

    Product Code Device Name
    MNB Device, Thermal Ablation, Endometrial